Hyterra Ltd. has released a press release.
BrainZ launches latest model infant brain monitor in Europe
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from HyTerra
- New funding for clinical trial using BrainZ technology
- Clinical Trials and cash position
- Commitments Test Entity - Fourth Quarter Report
- Commitments Test Entity - Second Quarter Report
- BrainZ extends distribution agreement with GE Healthcare
Later from HyTerra
- BrainZ BRM3 infant brain monitor receives US FDA clearance
- Revenues from new BRM3 monitor expected in December quarter
- Pilot Study shows Better Seizure Management using RecogniZe
- Half Yearly Report and Accounts
- Investor update - RecogniZe
Follow HyTerra into a list and get an email when it puts out news.
Follow HyTerra